Share-based payments - IPO Grant Shares (Details) - Equity Settled Awards € / shares in Units, € in Thousands |
1 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|
|
May 31, 2023
shares
$ / shares
|
May 31, 2023
shares
€ / shares
|
Dec. 31, 2023
EUR (€)
|
Dec. 31, 2022
EUR (€)
|
Dec. 31, 2021
EUR (€)
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] | |||||
| Weighted average fair value price (in USD or Euro per share) | (per share) | $ 2.13 | € 1.97 | |||
| Share-based payment expenses - SPAC Transaction | € | € 19 | € 0 | € 0 | ||
| Employees Instrumental In IPO | |||||
| Disclosure of terms and conditions of share-based payment arrangement [line items] | |||||
| Granted during the period (in shares) | 100 | 100 | |||
| Employees | |||||
| Disclosure of terms and conditions of share-based payment arrangement [line items] | |||||
| Granted during the period (in shares) | 9,600 | 9,600 | |||
| X | ||||||||||
- Definition Weighted Average Fair Value Price At Measurement Date, Other Equity Instruments Granted No definition available.
|
| X | ||||||||||
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. No definition available.
|
| X | ||||||||||
- Definition The amount of expense arising from share-based payment transactions in which the goods or services received did not qualify for recognition as assets. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|